Prostate-specific antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy

被引:0
|
作者
N Hayashi
M Urashima
I Ikemoto
H Kuruma
Y Arai
S Kuwao
S Baba
S Egawa
机构
[1] Jikei University School of Medicine,Department of Urology
[2] Jikei University School of Medicine,Division of Clinical Research and Development
[3] Tohoku University Graduate School of Medicine,Department of Urology
[4] Higashi-Yamato Hospital,Department of Pathology
[5] Kitasato University School of Medicine,Department of Urology
来源
关键词
prognosis; PSA; tumor volume; PSA tumor density;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to investigate the potential prognostic value of preoperative serum prostate-specific antigen levels adjusted for total tumor volume (PSA-TTV density) for outcome following radical prostatectomy for prostate cancer by retrospective review in 268 patients. Lower PSA-TTV density was not only associated with a significantly higher risk for biological failure (bF), systemic failure and cancer death but also an independent predictor for bF (hazard ratio, 6.3). Therefore, these data suggest that there are subsets of prostate cancer with lower PSA secretion levels, and this phenotype is associated with a higher risk of failure after surgery.
引用
收藏
页码:60 / 65
页数:5
相关论文
共 50 条
  • [1] Prostate-specific antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy
    Hayashi, N.
    Urashima, M.
    Ikemoto, I.
    Kuruma, H.
    Arai, Y.
    Kuwao, S.
    Baba, S.
    Egawa, S.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (01) : 60 - 65
  • [2] Nonpalpable, prostate-specific antigen detected prostatic carcinoma: Disease outcome after irradiation or radical prostatectomy
    Haddock, MG
    Kozelsky, TF
    Pisansky, TM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 216 - 216
  • [3] Elimination kinetics of prostate-specific antigen as predictor of prognosis after radical prostatectomy
    Hamm, M
    Semjonow, A
    Oberpenning, F
    Mandt, S
    Rathert, P
    [J]. AKTUELLE UROLOGIE, 1996, 27 (06) : 385 - 389
  • [5] Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomy
    Lein, M
    Brux, B
    Jung, K
    Henke, W
    Koenig, F
    Stephan, C
    Schnorr, D
    Loening, SA
    [J]. EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1997, 35 (08): : 591 - 595
  • [6] Artificial Prostate-Specific Antigen Persistence After Radical Prostatectomy
    Poyet, Cedric
    Hof, Danielle
    Sulser, Tullio
    Muentener, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : E62 - E63
  • [7] URINARY PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADICAL PROSTATECTOMY
    TAKAYAMA, TK
    VESSELLA, RL
    BRAWER, MK
    TRUE, LD
    NOTEBOOM, J
    LANGE, PH
    [J]. JOURNAL OF UROLOGY, 1994, 151 (01): : 82 - 87
  • [8] Maximum Tumor Diameter and the Risk of Prostate-Specific Antigen Recurrence After Radical Prostatectomy
    Rose, Brent S.
    Chen, Ming-Hui
    Zhang, Danjie
    Hirsch, Michelle S.
    Richie, Jerome P.
    Chang, Stephen L.
    Hegde, John V.
    Loffredo, Marian J.
    D'Amico, Anthony V.
    [J]. CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : E173 - E179
  • [9] Radical prostatectomy: Survival outcome and correlation to prostate-specific antigen levels
    Oberpenning, F
    Hamm, M
    Schmid, HP
    Hertle, L
    Semjonow, A
    [J]. ANTICANCER RESEARCH, 2000, 20 (6D) : 4969 - 4972
  • [10] Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
    Avci, Sinan
    Onen, Efe
    Caglayan, Volkan
    Kilic, Metin
    Sambel, Murat
    Oner, Sedat
    [J]. ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (01) : 1 - 6